CD40LG and coinfection: This province-wide study revealed a substantial burden of HEV coinfection among patients with chronic HBV in Hebei, China, with 18.70% anti-HEV seroprevalence (IgG+: 18.57%, IgM+: 0.64%) and 0.51% active viremia (HEV RNA+).